1. Quality Assurance Committees
  2. UW HRPP Quality Assurance
  3. Good Clinical Practice (GCP) Refresher Instructions
  4. Human Research Protection Program (HRPP) Newsletter - Fall 2016
  5. Human Research Protection Program (HRPP) Newsletter - Spring 2016
  6. Human Research Protection Program (HRPP) Newsletter - Spring 2017
  7. Additional Requirements When Conducting Human Subjects Research with Department of Defense (DOD) Support
  8. Additional Requirements When Conducting Human Subjects Research with Department of Education (ED) Support
  9. Additional Requirements When Conducting Human Subjects Research with Department of Energy (DOE) Support
  10. Additional Requirements When Conducting Human Subjects Research with Department of Justice (DOJ) Support
  11. Additional Requirements When Conducting Human Subjects Research with Environmental Protection Agency (EPA) Support
  12. Application of Federalwide Assurance (FWA) Terms to UW-Madison Human Participants Research Policy
  13. Campus IT Policies
  14. Certificate of Confidentiality (CoC) Application Help
  15. Changes in Research Activities: Submission and Review
  16. Clinical Trials Registration & Results Reporting
  17. Common Rule (45 CFR 46)
  18. Compliance Monitoring and Quality Improvement
  19. Compliance with Human Research Protections in Sponsored Research
  20. Conflicts of Interest of Non-UW-Madison Key Personnel
  21. Considerations for Accepting or Ceding IRB Review Guidance
  22. Contact Information for Reporting Suggestions and Concerns
  23. Continuing Review: Submission and Review
  24. Creation and Dissemination of Policies and Related Documentation
  25. Cross-Campus Human Research Protection Program (HRPP) Committee Charter
  26. De-Identified Publicly Available Datasets Guidance
  27. Developing an Internal Quality Assurance (QA) Program Guidance
  28. ED/SBS IRB Principal Investigator Responsibilities
  29. Engagement in Human Participants Research at UW–Madison
  30. Equitable Selection of Research Participants Guidance
  31. Exceptions to Informed Consent Requirements in Emergency Situations
  32. Exempt Research
  33. FDA IRB Regulations (21 CFR 56)
  34. Good Clinical Practice (GCP) Training Guidance and Instructions
  35. HRPP and IRB Resources
  36. HRPP Education and Training
  37. HRPP Guidance, Forms and Resources
  38. HRPP Newsletter - Spring 2018
  39. Human Research Protection Program Newsletter
  40. Human Subjects Research Protection Program (HRPP) Policy Index
  41. Initial Review: Submission and Review Policy
  42. Institutional Official in Charge of HRPP
  43. Instructions for Completing CITI Human Participants Research Training
  44. Instructions for Completing CITI Refresher Training
  45. Instructions for Linking Previous CITI Training to Your NetID
  46. Investigating the Cause of Noncompliance and Implementing Corrective and Preventive Action (CAPA) Plans Guidance
  47. IRB Analysis of Risks and Benefits of Research Guidance
  48. IRB Authority and Independence
  49. IRB Composition and Quality Performance
  50. IRB Consultants Use and Conflict of Interest
  51. IRB Meeting Minutes and Regulatory Documentation
  52. IRB Meetings
  53. IRB Members’ Conflicts of Interest
  54. IRB Purview
  55. IRB Reliance
  56. IRB Review of Study Resources
  57. Issues in Human Subjects Research When State Law May Apply
  58. List of Approved De-Identified Publicly Available Datasets
  59. Maintenance of IRB Records
  60. Monitoring the Consent Process
  61. NIH Genomic Data Sharing Policy for Human Data Guidance
  62. Noncompliance
  63. Obtaining and Documenting Informed Consent
  64. Office for Human Research Protections (OHRP) - IRB Knowledge of Local Research Context
  65. OHRP Guidance on Engagement of Institutions in Human Subjects Research
  66. OPRR Guidance on 45 CFR 46.101(b)(5): Exemption for Research and Demonstration Projects on Public Benefit and Service Programs
  67. Post Approval Monitoring Program Services
  68. Post-Approval Monitoring Program
  69. Preventing Noncompliance Guidance
  70. Principal Investigator Status for UW–Madison Studies Involving Human Participants
  71. Protecting Research Participants Privacy Interests and Confidentiality of Data
  72. Recruitment of Research Participants Guidance
  73. Reportable Abuse and Neglect Guidance
  74. Reporting of Suggestions and Concerns Regarding HRPP Performance and Function
  75. Reporting of Suggestions and Concerns Regarding the Protection of Research Participants
  76. Reporting to Institutional and External Authorities
  77. Research Participants
  78. Research with Adult Participants Lacking Capacity to Consent
  79. Retention of IRB Records
  80. Review of Data and Safety Monitoring in Research
  81. Review of Research Involving Vulnerable Participants
  82. Single Institutional Review Board (IRB) for Multi-Site Federal Grants Policy
  83. Student Research
  84. Study Closure
  85. Suspension and Termination of Approved Research
  86. Unanticipated Problems
  87. Use of Human Fetal Tissue in Research
  88. Use of Human Fetal Tissue in Research Policy Links
  89. UW Human Research Protection Program Newsletter - Fall 2015
  90. UW Post-Approval Monitors
  91. UW-Madison HIPAA Program
  92. UW–Madison Federalwide Assurance (FWA) & IRB Registration Numbers